T-cell

Car-T Technology: investors rely on immunotherapy to kill cancer

Car-T Technology: investors rely on immunotherapy to kill cancer

Autolus, London start-up, got multimillion financing and took a step towards implementation in the UK of “living medicine” in cancer therapies as…